| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 95144 |
|
3,636 |
709 |
$1.47M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
27,121 |
22,491 |
$1.27M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,263 |
4,873 |
$358K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,810 |
2,645 |
$235K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,114 |
2,001 |
$161K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,593 |
1,502 |
$135K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
1,409 |
1,349 |
$119K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
758 |
664 |
$71K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
571 |
515 |
$44K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
854 |
645 |
$43K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,080 |
900 |
$38K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
323 |
317 |
$21K |
| 90734 |
|
1,112 |
975 |
$15K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
575 |
523 |
$13K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
375 |
320 |
$12K |
| 95923 |
|
153 |
133 |
$10K |
| 90686 |
|
814 |
737 |
$8K |
| 81025 |
|
1,730 |
1,481 |
$7K |
| 95921 |
|
147 |
128 |
$7K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
194 |
186 |
$5K |
| 90715 |
|
409 |
356 |
$4K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
226 |
170 |
$3K |
| 90649 |
|
98 |
92 |
$2K |
| 81000 |
|
794 |
712 |
$2K |
| 90716 |
|
170 |
145 |
$2K |
| 90707 |
|
144 |
123 |
$1K |
| 99383 |
|
19 |
19 |
$1K |
| 99384 |
|
15 |
15 |
$1K |
| 81002 |
|
436 |
417 |
$1K |
| 90700 |
|
118 |
97 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
61 |
50 |
$937.39 |
| 90713 |
|
93 |
77 |
$848.77 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
31 |
29 |
$783.90 |
| 95117 |
|
40 |
38 |
$415.00 |
| 95115 |
|
24 |
19 |
$149.50 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
39 |
39 |
$0.00 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
19 |
14 |
$0.00 |
| 3079F |
|
135 |
120 |
$0.00 |
| 3075F |
|
135 |
120 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
130 |
126 |
$0.00 |